Junji Suzumiya - Concepedia

Author

Junji Suzumiya

Also Known As

Fumiya Wada, J Suzumiya, J. SUZUMIYA, J. Suzumiya, JUNJI SUZUMIYA, Junji SUZUMIYA, Junji Suzumiya, Koji Kato, PESCARMONA, Edoardo

366

Publications

11.1K

Citations

H-Index

112

Concepts

All Affiliations

Fukuoka University Shimane University Hospital Kyushu University Nagoya University Aichi Cancer Center

About

Junji Suzumiya is an author at Fukuoka University specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	84	4.5K
2	Health Sciences	10	11	300
3	Allergy	2	2	47
4	Allergy Medicine	1	1	25
5	Biochemistry	1	1	17

Junji Suzumiya

162

Publications

10.2K

Citations

H-Index

Page 1

	Year	Citations
Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study Motoko Yamaguchi, Yok‐Lam Kwong, Won Seog Kim, Journal of Clinical Oncology	2011	596
Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders Constitute a Distinct Clinicopathologic Group: A Study of 96 Patients Takashi Oyama, Kazuhito Yamamoto, Naoko Asano, Clinical Cancer Research	2007	454
Senile EBV+ B-Cell Lymphoproliferative Disorders Takashi Oyama, Koichi Ichimura, Ritsuro Suzuki, The American Journal of Surgical Pathology Lymphoid NeoplasiaAutoimmune DiseaseElderly PatientsEpstein-barr VirusImmunodeficiencies	2003	395
Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma Michinori Ogura, Takashi Ishida, Kiyohiko Hatake, Journal of Clinical Oncology	2014	357
Treatment and survival among 1594 patients with ATL Hiroo Katsuya, Kenji Ishitsuka, Atae Utsunomiya, Blood	2015	302
Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen Yujiro Asada, Akinobu Sumiyoshi, Tohru Hayashi, Thrombosis Research Viii Related AntigenThrombosisThrombopoiesisVenous ThrombosisHematology	1985	287
Expression of FoxP3, a key molecule in CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells, in adult T‐cell leukaemia/lymphoma cells Kennosuke Karube, Koichi Ohshima, Takeshi Tsuchiya, British Journal of Haematology	2004	281
Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type Ritsuro Suzuki, Junji Suzumiya, Motoko Yamaguchi, Annals of Oncology Prognostic FactorsLymphoid NeoplasiaMedicineImmunologyPathology	2009	257
Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells Ritsuro Suzuki, Junji Suzumiya, Shôji Nakamura, Leukemia Hematological MalignancyLymphoid NeoplasiaCytotoxic Nk CellsMalignant Blood DisorderImmunology	2004	238
Phase I study of dexamethasone, methotrexate, ifosfamide, <scp>l</scp>‐asparaginase, and etoposide (SMILE) chemotherapy for advanced‐stage, relapsed or refractory extranodal natural killer (NK)/T‐cell lymphoma and leukemia Motoko Yamaguchi, Ritsuro Suzuki, Yok‐Lam Kwong, Cancer Science ImmunologyRefractory DiseasesImmunotherapeuticsPharmacotherapyMetronomic Chemotherapy	2008	207

Page 1